KIARO AI Readiness intelligence

Built for human-accountable review

AI-assisted readiness intelligence for pharma material review

Kiaro helps medical, regulatory, compliance and copy approval teams find evidence gaps, readiness risks and recurring review issues before final human sign-off.

Request pilot access See how Kiaro works

Decision support, not automatic approval. Authorised reviewers remain accountable for final assessment and sign-off.

Proud to collaborate with Microsoft for Startups

Kiaro AI is part of Microsoft for Startups.Built and hosted on Microsoft Azure.

Illustrative workspace · No live data
KIARO AI
Human sign-off required
Promotional material · page 2 of 6 Annotated view
HCP EDUCATIONAL MATERIAL

Supporting confident treatment conversations

A concise overview of evidence, appropriate patient context and safety information.

Clinical evidence supports a meaningful improvement in outcomes for eligible patients when assessed in the context of the authorised indication.

1
EvidencePrimary endpoint summary
ContextPopulation and limitations

Prescribing decisions should consider current authorised product information, including safety and monitoring information.

2
Reference 1Prescribing information
Human final sign-off remains required
Designed for pharma promotional review
Source-aware findings and evidence checks
Annotated outputs and structured records
Governance and audit support

From context to confidence

A connected review loop for evidence-aware decisions.

Kiaro brings material context, evidence signals, reviewer action and recurring patterns into one traceable readiness view.

  1. 01Prepare the review context

    Bring material, references and the questions that matter into one focused scope.

  2. 02Surface readiness signals

    Examine content against supplied evidence, product information and applicable guidance.

  3. 03Resolve and record

    Connect potential issues to relevant material context and shape reviewer-ready outputs.

  4. 04Learn across activity

    Turn repeated signals into a sharper view of review pressure and governance priorities.

The Kiaro difference

A clearer path from evidence to reviewer judgement.

Kiaro connects the signals teams need without turning the decision into a black box.

01 · GROUNDED

Source-grounded

Keep evidence and review context visible as potential issues are surfaced.

02 · REVIEWER-LED

Reviewer-led

Support professional judgement without presenting an automated approval decision.

03 · PROCESS-AWARE

Process-aware

Make repeated patterns useful for the next review conversation and governance cycle.

Core capabilities

Practical readiness support across the review lifecycle.

Built around the artefacts and questions review teams already work with—not a separate black-box approval process.

01 · REVIEW

Promotional material readiness review

Helps teams triage potential issues before authorised reviewers make the final decision.

02 · EVIDENCE

Claim and evidence-gap detection

Surfaces claims that may be unsupported, weakly substantiated or missing usable references.

03 · ALIGNMENT

Product information and safety alignment

Supports focused assessment against supplied guidance, product information and safety context.

04 · OUTPUTS

Annotated reviewer outputs

Places clear findings near the relevant material context for focused reviewer follow-up.

05 · TRACEABILITY

Structured review records

Creates records that support follow-up, governance conversations and auditability.

06 · COMPANION

Reviewer companion workspace

Supports scoped conversations about evidence, guidance and surfaced readiness signals.

07 · INTELLIGENCE

Readiness and governance intelligence

Aggregates recurring review signals into leadership-ready insight and recommended areas for process improvement.

Explore intelligence

Signals across review activity

See where review pressure is recurring—not just where the last finding appeared.

Kiaro can turn aggregated pilot activity into a periodic intelligence view for medical, regulatory, compliance and operational leaders.

Readiness intelligence, not certification. Reports support process insight and governance; they do not certify compliance or replace professional review.

KIARO AIReadiness insights
Illustrative view Human final sign-off required
EXECUTIVE SIGNAL Review activity is stable, with repeat signals concentrated in evidence support and source currency.

Use recurring signals to focus the next review period.

Review signalStableActivity trend
Finding themesRecurringPattern visibility
Evidence qualityStrongSource context
Reviewer signalUsefulHuman feedback
Review signal over timeExample trend
Week 1Week 6Week 12
Recurring risk themesShare
Evidence alignmentHigh
Claim supportElevated
Safety wordingMonitor
Reference currencyMonitor
Strengthen evidence support

Reinforce source expectations at material intake.

Improve source currency

Confirm current material in each reference set.

Track reviewer signals

Use human feedback to refine focus areas.

Illustrative interface and synthetic data · No customer or live review information

Human accountability by design

Professional judgement stays at the centre of every review.

Kiaro supports professional review. It does not replace medical, regulatory or compliance judgement, and it does not approve or certify material automatically.

01

Final approval and sign-off remain with the customer’s authorised reviewers.

02

Findings should be assessed for the relevant product, market and intended audience.

03

Reviewers should consider current source materials, applicable codes and company procedures.

04

Kiaro helps surface potential issues; it does not guarantee compliance or eliminate risk.

A controlled path to value

Test Kiaro against a defined review workflow.

A focused pilot can help your team understand where AI-assisted readiness review adds practical value while preserving your governance and final sign-off process.

  • Faster first-pass triage for material entering review.
  • More consistent issue identification across reviewers and formats.
  • Clearer evidence and reference gaps before final assessment.
  • Better visibility of repeated problems across review activity.
  • More useful annotated outputs for focused reviewer follow-up.
  • Improved governance conversations across cross-functional teams.
REQUEST A PILOT CONVERSATION

Request pilot access

Tell us a little about your review environment. Please do not include patient data, confidential materials or review content.

Pilot requests are sent securely to Kiaro’s private business inbox. Please do not include patient data, confidential materials or review content.

Start with a focused conversation

Explore where readiness intelligence could support your review team.

Request pilot access